Literature DB >> 21233847

Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy.

W-J Lu1, N P Lee, S C Kaul, F Lan, R T P Poon, R Wadhwa, J M Luk.   

Abstract

Stress protein mortalin is a multifunctional protein and is highly expressed in cancers. It has been shown to interact with tumor suppressor protein-p53 (both wild and mutant types) and inactivates its transcriptional activation and apoptotic functions in cancer cells. In the present study, we found that, unlike most of the cancer cells, HepG2 hepatoma lacked mortalin-p53 interaction. We demonstrate that the mortalin-p53 interaction exists in cancer cells that are either physiologically stressed (frequently associated with p53 mutations) or treated with stress-inducing chemicals. Targeting mortalin-p53 interaction with either mortalin small hairpin RNA or a chemical or peptide inhibitor could induce p53-mediated tumor cell-specific apoptosis in hepatocellular carcinoma; p53-null hepatoma or normal hepatocytes remain unaffected.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233847      PMCID: PMC3131943          DOI: 10.1038/cdd.2010.177

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

Review 1.  Intrinsic tumour suppression.

Authors:  Scott W Lowe; Enrique Cepero; Gerard Evan
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

2.  Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus.

Authors:  P Shaw; J Freeman; R Bovey; R Iggo
Journal:  Oncogene       Date:  1996-02-15       Impact factor: 9.867

3.  ADP-ribosylation of p53 tumor suppressor protein: mutant but not wild-type p53 is modified.

Authors:  J Wesierska-Gadek; A Bugajska-Schretter; C Cerni
Journal:  J Cell Biochem       Date:  1996-07       Impact factor: 4.429

4.  Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival.

Authors:  Sinclair R Dundas; Laura C Lawrie; Patrick H Rooney; Graeme I Murray
Journal:  J Pathol       Date:  2005-01       Impact factor: 7.996

5.  Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell.

Authors:  B Sepehrnia; I B Paz; G Dasgupta; J Momand
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

6.  Mdm2 association with p53 targets its ubiquitination.

Authors:  S Y Fuchs; V Adler; T Buschmann; X Wu; Z Ronai
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

7.  Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member.

Authors:  R Wadhwa; S Takano; M Robert; A Yoshida; H Nomura; R R Reddel; Y Mitsui; S C Kaul
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

8.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.

Authors:  E Yonish-Rouach; D Resnitzky; J Lotem; L Sachs; A Kimchi; M Oren
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

9.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

10.  Interaction between hsp70 and hsp40, eukaryotic homologues of DnaK and DnaJ, in human cells expressing mutant-type p53.

Authors:  K Sugito; M Yamane; H Hattori; Y Hayashi; I Tohnai; M Ueda; N Tsuchida; K Ohtsuka
Journal:  FEBS Lett       Date:  1995-01-23       Impact factor: 4.124

View more
  66 in total

Review 1.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

2.  Circulating mortalin autoantibody--a new serological marker of liver cirrhosis.

Authors:  Wen-Jing Lu; Nishant Saxena; John M Luk; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2015-04-24       Impact factor: 3.667

3.  Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.

Authors:  Renu Wadhwa; Jihoon Ryu; Hyo Min Ahn; Nishant Saxena; Anupama Chaudhary; Chae-Ok Yun; Sunil C Kaul
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

4.  Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53.

Authors:  Satish K Ramraj; Sugantha P Elayapillai; Richard C Pelikan; Yan D Zhao; Zitha R Isingizwe; Amy L Kennedy; Stanley A Lightfoot; Doris M Benbrook
Journal:  Int J Cancer       Date:  2020-01-08       Impact factor: 7.396

5.  A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase.

Authors:  Pui-Kei Wu; Seung-Keun Hong; Sudhakar Veeranki; Mansi Karkhanis; Dmytro Starenki; Jose A Plaza; Jong-In Park
Journal:  Mol Cell Biol       Date:  2013-08-19       Impact factor: 4.272

6.  Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.

Authors:  Marie Duhamel; Mélanie Rose; Franck Rodet; Adriana Natalia Murgoci; Lea Zografidou; Anne Régnier-Vigouroux; Fabien Vanden Abeele; Firas Kobeissy; Serge Nataf; Laurent Pays; Maxence Wisztorski; Dasa Cizkova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2018-03-12       Impact factor: 5.911

7.  Role of the HSPA9/HSC20 chaperone pair in promoting directional human iron-sulfur cluster exchange involving monothiol glutaredoxin 5.

Authors:  Joshua A Olive; J A Cowan
Journal:  J Inorg Biochem       Date:  2018-04-11       Impact factor: 4.155

Review 8.  A model in which heat shock protein 90 targets protein-folding clefts: rationale for a new approach to neuroprotective treatment of protein folding diseases.

Authors:  William B Pratt; Yoshihiro Morishima; Jason E Gestwicki; Andrew P Lieberman; Yoichi Osawa
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-02

9.  Identification and functional characterization of nuclear mortalin in human carcinogenesis.

Authors:  Jihoon Ryu; Zeenia Kaul; A-Rum Yoon; Ye Liu; Tomoko Yaguchi; Youjin Na; Hyo Min Ahn; Ran Gao; Il-Kyu Choi; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

10.  Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy.

Authors:  Sanam Sane; Ammara Abdullah; Morgan E Nelson; Hongmin Wang; Subhash C Chauhan; Samuel S Newton; Khosrow Rezvani
Journal:  Cell Stress Chaperones       Date:  2015-12-04       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.